La Jolla Pharmaceutical (LJPC) Reports Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC-401 in ...
StreetInsider.com “I am excited to be included in the clinical evaluation of a treatment that harnesses the body's natural mechanism for iron regulation in a patient-friendly treatment regimen that could potentially reduce or eliminate the need for phlebotomy procedures ... |
from phlebotomy - Google News http://bit.ly/2DGujot
No comments:
Post a Comment